When assessed together with their clinical survival follow‐up data, the results showed that patients with high mPRα expression in lung adenocarcinoma had poor overall survival prognosis, suggesting high mPRα expression is correlated with poor prognosis in patients with lung adenocarcinoma (P < 0.01) (Fig 1c). Here, PAQR7 is linked to lung adenocarcinoma.